New York State Psychiatric Association

NYSPA Issues Press Release on SAFE Act Reporting Requirements

Recently, NYSPA has been mentioned in several newspaper articles regarding the SAFE Act reporting requirements. 

Read more...
 

NYSPA Honors C. Deborah Cross, M.D. with Distinguished Service Award

At its Spring meeting on March 22, 2014, the NYSPA Council awarded the NYSPA Distinguished Service Award to C. Deborah Cross, M.D. in recognition of her dedication, prodigious effort, intelligence and leadership in the profession of Psychiatric Medicine nationally and in the State of New York.   

Read more...
 

NYSPA Provides Testimony on SAFE Act Reporting Requirement 

 
On May 31, 2013, NYSPA presented testimony at a Senate hearing regarding the impact of the SAFE Act mental health reporting requirement. 

Read more...
 

100% Pre-Payment Review of CPT Code 99214

 
Medicare has initiated a special targeted pre-payment review of all CPT code 99214 services.  After conducting a review of documentation for this level outpatient office visit for an established patient, Medicare has concluded that the documentation often failed to meet the CPT documentation requirements for this service.  Psychiatrists may be using Code 99214 in combination with an add-on psychotherapy visit such as 90833, 90836, or 90838.  NYSPA has prepared a guideline for minimum documentation requirements for Code 99214.  Members can click here to read and download the NYSPA guidelines. Failure to record the minimum required documentation for a Code 99214 can result in disallowance or reduction to a lower level E/M code and recovery of overpayments.

Under pre-payment review, your claim will be pended until documentation is reviewed. If you do not respond to the records request, the claim will be denied.

 

PQRS Clarification

In response to our recent website article on the new PQRS 2015 payment reduction, NYSPA has received several inquiries from members regarding the use of Measure #9 (Major Depressive Disorder (MDD): Antidepressant Medication During Acute Phase for Patients with MDD)

Read more...
 
<< first < Prev 1 2 3 4 5 6 7 8 9 10 Next > last >>

Page 2 of 13